Detalles de la búsqueda
1.
A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants.
BMC Med
; 19(1): 138, 2021 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34098951
2.
Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
Clin Infect Dis
; 61(11): 1637-44, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26374816
3.
Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides.
Hum Vaccin Immunother
; 20(1): 2330138, 2024 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38608170
4.
A Randomized Trial Assessing the Immunogenicity and Reactogenicity of Two Hexavalent Infant Vaccines Concomitantly Administered With Group B Meningococcal Vaccine.
Pediatr Infect Dis J
; 42(1): 66-73, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36476534
5.
Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, equivalence, randomised controlled trial.
Lancet Microbe
; 4(5): e300-e308, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37080224
6.
An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in England.
Vaccine
; 40(49): 7050-7056, 2022 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36272877
7.
Serological responses to Anthrax Vaccine Precipitated (AVP) increase with time interval between booster doses.
Vaccine
; 40(42): 6163-6178, 2022 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36153153
8.
Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis.
Clin Infect Dis
; 52(1): 70-7, 2011 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21148522
9.
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial.
Lancet Infect Dis
; 21(5): 688-696, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33428870
10.
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study.
Lancet Infect Dis
; 21(4): 507-516, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33065039
11.
Estimation of ELISA results using a parallel curve analysis.
J Immunol Methods
; 486: 112836, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32827492
12.
Acellular Pertussis Vaccines Induce Anti-pertactin Bactericidal Antibodies Which Drives the Emergence of Pertactin-Negative Strains.
Front Microbiol
; 11: 2108, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32983069
13.
Pertussis Antibody Concentrations in Infants Born Prematurely to Mothers Vaccinated in Pregnancy.
Pediatrics
; 138(1)2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27255149
14.
Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool Age.
Pediatr Infect Dis J
; 34(8): 865-74, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26075813
15.
Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule.
Vaccine
; 33(5): 648-55, 2015 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25510388
16.
Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease.
Clin Vaccine Immunol
; 19(11): 1776-83, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22956654
17.
Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdom.
Pediatr Infect Dis J
; 31(6): 616-22, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22333698
18.
Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age.
Clin Vaccine Immunol
; 18(3): 367-72, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21191076
19.
Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
Clin Vaccine Immunol
; 16(8): 1113-20, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19553555
20.
The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
Vaccine
; 23(17-18): 2210-3, 2005 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-15755597